A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2006
10/19/2006	CA2604397A1 Process for preparing bicyclic compounds
10/19/2006	CA2604291A1 Compounds which inhibit beta-secretase activity and methods of use thereof
10/19/2006	CA2603959A1 Therapeutic agent for dyskinesia
10/19/2006	CA2603701A1 1,4-substituted piperazine derivative
10/19/2006	CA2603457A1 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
10/19/2006	CA2603402A1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
10/19/2006	CA2603320A1 Pyridylmethylsulfone derivative
10/19/2006	CA2602968A1 Crystals of morphinan derivative and process for producing the same
10/19/2006	CA2601986A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
10/18/2006	EP1712239A2 Interleukin-1 inhibitors in the treatment of diseases
10/18/2006	EP1712232A1 Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
10/18/2006	EP1712227A1 Amino diols useful in the treatment of Alzheimer's disease
10/18/2006	EP1712225A1 Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists
10/18/2006	EP1711530A2 Nogo-a neutralising immunoglobulins for treatment of neurological diseases
10/18/2006	EP1711465A1 Hydroisoindoline tachykinin receptor antagonists
10/18/2006	EP1711230A1 Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism
10/18/2006	EP1711191A2 Chlorite in the treatment of neurodegenerative disease
10/18/2006	EP1711177A1 1H-THIENO 2,3-c PYRAZOLE DERIVATIVES USEFUL AS KINASE I INHIBITORS
10/18/2006	EP1711167A1 Multiparticulate o-desmethylvenlafaxine salts and uses thereof
10/18/2006	EP1711124A1 Long-term delivery formulations and methods of use thereof
10/18/2006	EP1567146B1 Iontophoretic delivery of rotigotine for the treatment of parkinson's disease
10/18/2006	EP1423112B1 A combination of quetiapine and zolmitriptan
10/18/2006	EP1339714B1 Novel sulfonamide-substituted pyrazolopyridine derivatives
10/18/2006	EP1283828B1 Novel polymorph v of torasemide
10/18/2006	EP1180039B1 Composition for the treatment of a neurological disorder
10/18/2006	EP1072266B8 Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
10/18/2006	EP1042468B1 Low-voltage activated calcium channel compositions and methods
10/18/2006	CN1849400A Polynucleotides and polypeptides of the erythropoietin gene
10/18/2006	CN1849325A Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting prot ein kinases
10/18/2006	CN1849315A Novel amides useful for treating pain
10/18/2006	CN1849312A Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics
10/18/2006	CN1849310A Thiazole derivatives as cannabinoid receptor modulators
10/18/2006	CN1849153A Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
10/18/2006	CN1849138A Human anti-NGF neutralizing antibodies as selective ngf pathway inhibitors
10/18/2006	CN1849131A Treating immunological disorders using agonists of interleukin-21 / interleukin-21 receptor
10/18/2006	CN1849127A Use of parapheny for maldehyde-O-beta-D-allose pyranoside for treating neurogenic pain
10/18/2006	CN1849116A Carbamate compounds for use in the treatment of pain
10/18/2006	CN1847261A Cyclic peptides as g-protein-coupled receptor antagonists
10/18/2006	CN1847246A Galantamine derivative and its prepn process and use
10/18/2006	CN1847244A Polymorphs of zaleplon and methods for the preparation thereof
10/18/2006	CN1847229A Novel compounds
10/18/2006	CN1846739A Hemiplegia treating Chinese medicine composition and its prepn process
10/18/2006	CN1846731A Psychosis treating medicine
10/18/2006	CN1846721A Tranquilizing seven-leaf oral cavity disintegrated tablet
10/18/2006	CN1846697A New use of angiotensin ii antagonists
10/18/2006	CN1846693A Control released permeation bump tablet of venlafaxine hydrochloride and its prepn process
10/18/2006	CN1846572A Hypertensive tranquilizing pillow
10/18/2006	CN1846515A Tobacco poison eliminating Sanshen health tea
10/18/2006	CN1280288C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
10/18/2006	CN1280259C Aryl aniline beta-2 adrenergic receptor agonists
10/18/2006	CN1279971C Novel method for down-regulation of amyloid
10/18/2006	CN1279943C Chinese medicine for treating brain disease
10/18/2006	CN1279931C Medicine for treating primary and secondary headache
10/18/2006	CN1279929C Chinese medicine for treating facial paralysis, preparing method and use
10/18/2006	CN1279906C Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof
10/18/2006	CN1279900C Gabapentin analogues for sleep disorders
10/18/2006	CN1279896C Tramadol hydrochloride oral disintegration tablets, and prepn. method therefor
10/17/2006	US7122682 Chemical intermediates used for manufacturing (S)-(-)- alpha -ethyl-2-oxo-1-pyrrolidine acetamide which is used in therapy and prophylaxis epilepsy and other neurological disorders
10/17/2006	US7122679 Multicyclic compounds and the use thereof
10/17/2006	US7122678 (Trans)-(3,4-Dimethyl-cyclopentyldine)-acetic acid ethyl ester; treating epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, irritable bowel syndrome (IBS), and inflammation
10/17/2006	US7122677 NK1 antagonists
10/17/2006	US7122675 Gamma secretase inhibitors
10/17/2006	US7122669 Purine derivatives, preparation method and pharmaceutical compositions containing same
10/17/2006	US7122576 Carbamate compounds for use in preventing or treating bipolar disorder
10/17/2006	US7122571 Substituted hydrazones as inhibitors of cyclooxygenase-2
10/17/2006	US7122565 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
10/17/2006	US7122562 Amine oxidase inhibitor; use in treatment of Alzheimer's disease and senile dementia
10/17/2006	US7122556 Phenylalanine enamide derivatives
10/17/2006	US7122552 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction
10/17/2006	US7122551 Metalloproteinase inhibitor compounds
10/17/2006	US7122550 Protein kinase inhibitors
10/17/2006	US7122546 GABAA (gamma-aminobutyric acid) receptor modulators; anxiolytic, antidepresant agents; attention deficit disorder, Alzheimer*s disease treatment; central nervous systmem disorders
10/17/2006	US7122545 Imidazo-benzothiazoles
10/17/2006	US7122544 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
10/17/2006	US7122538 Neuroleptic agents for treating schizophrenia, psychological disorders, depression; 5-(4-Chlorophenyl)-thiophene-2-sulfonic acid (8-methoxy-3-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)amide
10/17/2006	US7122537 Which has superoxide acitivity, catalase activity, and/or peroxidase activity; for treating cell or tissue damage; improved organ, cell or tissue culture; diseases such as neurodegenerative diseases
10/17/2006	US7122534 Aryl fused azapolycyclic compounds
10/17/2006	US7122532 Regulation of intracellular glucocorticoid concentrations
10/17/2006	US7122531 Regulation of intracellular glucocorticoid concentrations
10/17/2006	US7122524 Stimulating nerve growth, administering glycyl-L-phenylalanyl-L-prolineamide, N,N-diethyl-isoleucyl-phenylalanyl-L-proline ethylamide, N,N-diethyl-isoleucyl-isoleucyl-prolineamide; due to ischemic, traumatic or toxic origin
10/17/2006	US7122362 For diagnosing, treating, or preventing disorders associated with aberrant expression of human phosphodiesterases
10/17/2006	US7122326 Central nervous system disorders; psychological disorders
10/17/2006	US7122208 Administering aliquot of blood which has been treated ex vivo with stressors such as oxidation, thermal stress and electromagnetic radiation; wherein concentration of reactive oxygen species in neuronal cells or tissues is reduced
10/17/2006	US7122183 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L
10/17/2006	CA2447405C Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
10/17/2006	CA2395705C Substituted phenyl-piperazine derivatives, their preparation and use
10/17/2006	CA2339661C Use of derivatives of aryl(or heteroaryl)azolylcarbinols in the manufacture of a medicament for the treatment of disorders mediated by an excess of substance p
10/17/2006	CA2284976C Process for preparing single enantiomer narwedine
10/17/2006	CA2275686C Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors
10/17/2006	CA2253547C Benzofuryl derivatives and their use
10/17/2006	CA2250318C Sustained-release metal valproate tablets
10/17/2006	CA2244774C Dihydropyridine derivatives, their preparation and their use as adenosine receptor antagonists
10/17/2006	CA2238817C 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
10/17/2006	CA2182981C Sublingual or buccal pharmaceutical composition
10/17/2006	CA2177179C Antagonists to chaperonin 10
10/17/2006	CA2126305C New treatments using venlafaxine
10/12/2006	WO2006108151A1 Crystalline forms of pregabalin
10/12/2006	WO2006108055A1 Glutamate modulating agents in the treatment of mental disorders
10/12/2006	WO2006107948A2 Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents
10/12/2006	WO2006107784A1 Imidazopyridazine compounds

1 ... 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 ... 1833